279 related articles for article (PubMed ID: 20203164)
21. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
22. [A case of collapsing variant of FSGS].
Nagai C; Yokota S; Kido Y; Katayama N; Nishiya M; Koizumi H; Namiki M; Nakamoto Y
Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):47-52. PubMed ID: 10771575
[TBL] [Abstract][Full Text] [Related]
23. Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis.
Amoura A; Moktefi A; Halfon M; Karras A; Rafat C; Gibier JB; Gleeson PJ; Servais A; Argy N; Maillé P; Belenfant X; Gueutin V; Delpierre A; Tricot L; El Karoui K; Jourde-Chiche N; Houze S; Sahali D; Audard V
Clin J Am Soc Nephrol; 2020 Jul; 15(7):964-972. PubMed ID: 32444394
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of collapsing focal segmental glomerulosclerosis.
Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
[TBL] [Abstract][Full Text] [Related]
25. Acute kidney injury in primary nephrotic syndrome: report of nine cases in Siriraj Hospital.
Larpparisuth N; Chanchairujira T; Chawanasuntorapoj R; Choensuchon B; Vareesangthip K; Vasuvattakul S; Teerapornlertratt T
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S125-33. PubMed ID: 21721438
[TBL] [Abstract][Full Text] [Related]
26. Focal Segmental Glomerulosclerosis.
Rosenberg AZ; Kopp JB
Clin J Am Soc Nephrol; 2017 Mar; 12(3):502-517. PubMed ID: 28242845
[TBL] [Abstract][Full Text] [Related]
27. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
[TBL] [Abstract][Full Text] [Related]
30. Unusual Cause and Presentation of Collapsing Focal Segmental Glomerulosclerosis.
Bhat ZY; Sharma N; Pillai U; Singh A
Am J Ther; 2016; 23(3):e957-60. PubMed ID: 25420079
[TBL] [Abstract][Full Text] [Related]
31. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
32. T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS.
Chan CY; Liu ID; Resontoc LP; Ng KH; Chan YH; Lau PY; Than M; Jordan SC; Lam KP; Yeo WS; Yap HK
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1360-1368. PubMed ID: 27269610
[TBL] [Abstract][Full Text] [Related]
33. Obesity-related glomerulopathy: an emerging epidemic.
Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
[TBL] [Abstract][Full Text] [Related]
34. Focal Segmental Glomerulosclerosis (FSGS) Progressing to Collapsing Glomerulopathy in Renal Transplant Recipients With and Without COVID-19 Infection.
Thorburn CA; Samarapungavan D; Kanaan HD; Cohn S; Jabbar KJ; Li W; Bedi D; Suliman ST; Patel PJ; Putchakayala K; Singh A; Zhang PL
Transplant Proc; 2022; 54(6):1465-1470. PubMed ID: 35341587
[TBL] [Abstract][Full Text] [Related]
35. [Focal segmental glomerulosclerosis associated with type C virus hepatitis and decrement of proteinuria by interferon-alpha therapy].
Ezaki Y; Tanaka U; Minoshima S; Endou M; Kuwaki K; Arimura Y; Nakabayashi K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):83-8. PubMed ID: 10361424
[TBL] [Abstract][Full Text] [Related]
36. Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
Choi SB; Kim KM; Park MH; Kang KP
Medicine (Baltimore); 2021 May; 100(18):e25857. PubMed ID: 33951000
[TBL] [Abstract][Full Text] [Related]
37. Interventions for focal segmental glomerulosclerosis in adults.
Hodson EM; Sinha A; Cooper TE
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD003233. PubMed ID: 35224732
[TBL] [Abstract][Full Text] [Related]
38. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
39. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.
Thomas DB; Franceschini N; Hogan SL; Ten Holder S; Jennette CE; Falk RJ; Jennette JC
Kidney Int; 2006 Mar; 69(5):920-6. PubMed ID: 16518352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
